Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vice Health and Wellness is a Canadian public health and wellness company that evolved from The Gummy Project into a broader consumer wellness business. The company has marketed low-sugar, plant-based gummy products and has also described plans to develop Vice Versa AI, a digital health application focused on obesity, weight-loss, and addiction support. Available public disclosures portray the business more as a wellness and consumer health issuer than a traditional drug-development biotech company, with no clearly disclosed therapeutic pipeline, molecular targets, or clinical-stage assets. As of 2024, the company faced major regulatory and trading issues, including a cease trade order and suspension from trading on the Canadian Securities Exchange. Based on the latest accessible public information, it does not appear to be operating as an active clinical biopharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vice Health and Wellness.